Apr 26, 2023 / 12:00PM GMT
Operator
This meeting is being recorded (Operator Instructions). In addition to that, you may also raise your virtual hand to address your questions verbally. (Operator Instructions) One last remark, if you would like to follow the presented slides on your end as well, please feel free to go to roche.com/investors to download the presentation.
At this time, it's my pleasure to introduce you to Thomas Schinecker, CEO Roche Group. Mr. Schinecker, the stage is yours.
Thomas Schinecker - Roche Holding AG - CEO
Good morning, and good afternoon, everyone. Together with my team, I'm looking forward to presenting the Q1 2023 results. So let's get right into it.
Group sales declined by 3%, and this was driven by the expected decline in COVID-19 testing. The underlying base business in both divisions reported strong growth results, which meant for the group plus 8% for the base business. Pharma had a very strong performance in Q1 with plus 9%, and this was driven by the ongoing portfolio rejuvenation. We had also a good diagnostics base business growth of plus 4
Q1 2023 Roche Holding AG Corporate Sales Call Transcript
Apr 26, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers